Literature DB >> 15808190

Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.

Corinne Dot1, Joël Guigay, Grazyna Adamus.   

Abstract

PURPOSE: To present a case of cancer-associated retinopathy (CAR) in a patient with small cell carcinoma of the lung and antiretinal antibodies who experienced visual symptoms before diagnosis of cancer.
DESIGN: Case report.
METHODS: A 61-year-old man with a sudden loss of vision and photophobia was referred to the ophthalmology service. Antiretinal antibodies were determined by Western blot analysis.
RESULTS: The patient was found to have small cell carcinoma of the lung without metastasis and was surgically treated. His visual loss was asymmetrical. The full field ERG was normal, even though his vision in the right eye became progressively worse. The patient was treated with methylprednisolone and showed significant improvement. Before surgery, serum tests showed antiretinal protein 35-kD; 1 week after surgery, antiretinal protein 35-kD and 46-kD (alpha-enolase); and 1 month after surgery, anti-alpha-enolase.
CONCLUSIONS: Typical visual symptoms for paraneoplastic retinopathy are not always present. The absence of antirecoverin antibodies does not exclude a diagnosis of CAR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808190     DOI: 10.1016/j.ajo.2004.10.044

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.

Authors:  Agnieszka Magrys; Thimmappa Anekonda; Gaoying Ren; Grazyna Adamus
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

2.  [Arch-shaped retinal appearance of a previously healthy women].

Authors:  M Khattab; N Feltgen; S Bemme; H Hoerauf; M Storch
Journal:  Ophthalmologe       Date:  2017-07       Impact factor: 1.059

3.  Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.

Authors:  Ying Lu; Lin Jia; Shirley He; Mary C Hurley; Monique J Leys; Thiran Jayasundera; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2009-12

4.  Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.

Authors:  Griet Goetgebuer; Anna-Maria Kestelyn-Stevens; Jean-Jacques De Laey; Philippe Kestelyn; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2007-08-25       Impact factor: 2.379

5.  Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.

Authors:  Giovannella Carboni; Gina Forma; April D Bond; Grazyna Adamus; Alessandro Iannaccone
Journal:  Doc Ophthalmol       Date:  2012-05-09       Impact factor: 2.379

Review 6.  Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.

Authors:  Grazyna Adamus
Journal:  Autoimmun Rev       Date:  2009-01-23       Impact factor: 9.754

7.  Identification of Autoantibodies for α and γ-Enolase in Serum from a Patient with Melanoma.

Authors:  Yui Hiura; Toyofumi Nakanishi; Miki Tanioka; Takayuki Takubo; Shinichi Moriwaki
Journal:  Jpn Clin Med       Date:  2011-07-17

8.  Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.

Authors:  Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-13       Impact factor: 3.535

9.  Cancer-associated retinopathy in patients with breast carcinoma.

Authors:  Marta Misiuk-Hojło; Maria Ejma; Wojciech A Gorczyca; Stanisław Szymaniec; Danuta Witkowska; Wojciech Fortuna; Ryszard Miedzybrodzki; Jadwiga Rogozińska-Szczepka; Wiesława Bartnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

10.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.